Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 7352

1.
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

[Tuberculosis in compromised hosts].

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID:
14672050
4.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
5.

Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.

Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.

Am J Ther. 2011 Sep;18(5):343-9. doi: 10.1097/MJT.0b013e3181dd60ec.

PMID:
20535008
6.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.

7.

Treatment of multidrug-resistant tuberculosis in Thailand.

Maranetra KN.

Chemotherapy. 1996;42 Suppl 3:10-5; discussion 30-3. Review.

PMID:
8980862
8.
9.

TB control programmes: the challenges for Africa.

Harries T.

Afr Health. 1996 Nov;19(1):19-20.

PMID:
12291916
10.
11.

[Tuberculosis in Asia].

[No authors listed]

Kekkaku. 2002 Oct;77(10):693-7. Japanese.

PMID:
12440145
12.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

13.

Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.

Wilkinson D, Pillay M, Davies GR, Sturm AW.

Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):692-5.

PMID:
9015521
14.

The management of tuberculosis: epidemiology, resistance and monitoring.

Bang D.

Dan Med Bull. 2010 Nov;57(11):B4213. Review.

PMID:
21055374
15.

Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.

Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.

East Afr Med J. 1999 Jun;76(6):307-13.

PMID:
10750516
16.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N.

Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Review.

17.

Treatment of tuberculosis.

[No authors listed]

Child Health Dialogue. 1996 Apr-Jun;Suppl:8-9.

PMID:
12292166
18.

Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.

Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.

Int J Tuberc Lung Dis. 2002 Oct;6(10):858-64.

PMID:
12365571
20.

An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.

Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL.

AIDS. 1996 Mar;10(3):299-309.

PMID:
8882670

Supplemental Content

Support Center